Company: ACTG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0000934549-25-000021
Chunk: 131

Company: ACACIA RESEARCH CORP
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 8
Chunk 131
---
 2024, respectively. The Company did not record charges related to impairment of other intangible assets for the three months ended March 31, 2025 and 2024. There was no accelerated amortization of other intangible assets for the three months ended March 31, 2025 and 2024. Intellectual Property Operations amortization of patents was $4.5 million and $3.4 million for the three months ended March 31, 2025 and 2024, respectively, and is expensed in cost of revenues. Industrial Operations amortization of intangible assets was $435,000 and $433,000 for the three months ended March 31, 2025 and 2024, respectively. Manufacturing Operations amortization of intangible assets was $472,000 for the three months ended March 31, 2025. Industrial Operations and Manufacturing Operations amortization of intangible assets is expensed in general and administrative expenses.The following table presents the scheduled annual aggregate amortization expense (in thousands):Years Ending December 31,Remainder of 2025$18,853 202611,175 20278,736 20284,586 20292,003 20302,003 Thereafter11,837 Total$59,193 During the year ended December 31, 2022, ARG entered into an agreement granting ARG the exclusive option to acquire all rights to license and enforce a patent portfolio and all future patents and patent applications, and incurred $15.0 million of certain patent and patent rights costs, which was fully paid in 2023. The patent costs are included in prepaid expenses and other current assets in the condensed consolidated balance sheet as of December 31, 2024. During the three months 

25

ended March 31, 2025, ARG exercised the option to acquire all rights to license and enforce the portfolio and capitalized $15.0 million in patent and patent rights costs. 

9. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:March 31, 2025December 31, 2024(In thousands)Benchmark derivative$2,607 $— Accrued consulting and other professional fees893 2,602 Income taxes payable6,238 3,832 Sales and tax and fees payable6,084 4,818 Other tax payable1,049 2,046 Revolving